Literature DB >> 1674968

The inability of human immunodeficiency virus to infect chimpanzee monocytes can be overcome by serial viral passage in vivo.

H E Gendelman1, G D Ehrlich, L M Baca, S Conley, J Ribas, D C Kalter, M S Meltzer, B J Poiesz, P Nara.   

Abstract

Studies of lentivirus infection in ruminants, nonhuman primates, and humans suggest that virus infection of macrophages plays a central role in the disease process. To investigate whether human immunodeficiency virus type 1 (HIV-1) can infect chimpanzee macrophages, we recovered monocytes from peripheral blood mononuclear cells of HIV-1-negative animals and inoculated these and control human monocytes with a panel of four human-passaged monocytotropic virus strains and one chimpanzee-passaged isolate. HIV-1 infected human monocytes synthesized proviral DNA, viral mRNA, p24 antigen, and progeny virions. In contrast, except for the chimpanzee-passaged HIV-1 isolate, chimpanzee monocytes failed to support HIV-1 replication when cultured under both identical and a variety of other conditions. Proviral DNA was demonstrated only at background levels in these cell cultures by polymerase chain reaction for gag- and env-related sequences. Interestingly, the chimpanzee-passaged HIV-1 isolate did not replicate in human monocytes; viral p24 antigens and progeny virions were not detected. The same monocytotropic panel of HIV-1 strains replicated in both human and chimpanzee CD4+ T lymphoblasts treated with phytohemagglutinin and interleukin-2. The failure of HIV-1 to infect chimpanzee monocytes, which can be overcome by serial in vivo viral passage, occurs through a block early in the viral life cycle.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1674968      PMCID: PMC241416     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  30 in total

1.  T-cell-induced expression of human immunodeficiency virus in macrophages.

Authors:  R D Schrier; J A McCutchan; J C Venable; J A Nelson; C A Wiley
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

2.  Macrophage-HIV interaction: viral isolation and target cell tropism.

Authors:  H E Gendelman; L M Baca; H Husayni; J A Turpin; D Skillman; D C Kalter; J M Orenstein; D L Hoover; M S Meltzer
Journal:  AIDS       Date:  1990-03       Impact factor: 4.177

3.  Transmission experiments with human T-lymphotropic retroviruses and human AIDS tissue.

Authors:  D C Gajdusek; H L Amyx; C J Gibbs; D M Asher; R T Yanagihara; P Rodgers-Johnson; P W Brown; P S Sarin; R C Gallo; A Maluish
Journal:  Lancet       Date:  1984-06-23       Impact factor: 79.321

4.  Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro.

Authors:  M A Abbott; B J Poiesz; B C Byrne; S Kwok; J J Sninsky; G D Ehrlich
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

5.  A chimpanzee-passaged human immunodeficiency virus isolate is cytopathic for chimpanzee cells but does not induce disease.

Authors:  M Watanabe; D J Ringler; P N Fultz; J J MacKey; J E Boyson; C G Levine; N L Letvin
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

6.  Permissivity of primary cultures of human Kupffer cells for HIV-1.

Authors:  M P Schmitt; J L Gendrault; C Schweitzer; A M Steffan; C Beyer; C Royer; D Jaeck; J L Pasquali; A Kirn; A M Aubertin
Journal:  AIDS Res Hum Retroviruses       Date:  1990-08       Impact factor: 2.205

7.  Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120.

Authors:  L O Arthur; J W Bess; D J Waters; S W Pyle; J C Kelliher; P L Nara; K Krohn; W G Robey; A J Langlois; R C Gallo
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

8.  The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations.

Authors:  P Nara; W Hatch; J Kessler; J Kelliher; S Carter
Journal:  J Med Primatol       Date:  1989       Impact factor: 0.667

9.  Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction.

Authors:  G D Ehrlich; J B Glaser; K LaVigne; D Quan; D Mildvan; J J Sninsky; S Kwok; L Papsidero; B J Poiesz
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

10.  A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes.

Authors:  H E Gendelman; R M Friedman; S Joe; L M Baca; J A Turpin; G Dveksler; M S Meltzer; C Dieffenbach
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

View more
  9 in total

1.  Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.

Authors:  T Beaumont; S Broersen; A van Nuenen; H G Huisman; A M de Roda Husman; J L Heeney; H Schuitemaker
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis.

Authors:  I C Davis; M Girard; P N Fultz
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Priming of human CD4+ antigen-specific T cells to undergo apoptosis by HIV-infected monocytes. A two-step mechanism involving the gp120 molecule.

Authors:  F Cottrez; F Manca; A G Dalgleish; F Arenzana-Seisdedos; A Capron; H Groux
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

4.  Extensive diversification of human immunodeficiency virus type 1 subtype B strains during dual infection of a chimpanzee that progressed to AIDS.

Authors:  Q Wei; P N Fultz
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

5.  Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Authors:  Olivier Humbert; Frieda Chan; Yogendra S Rajawat; Troy R Torgerson; Christopher R Burtner; Nicholas W Hubbard; Daniel Humphrys; Zachary K Norgaard; Patricia O'Donnell; Jennifer E Adair; Grant D Trobridge; Andrew M Scharenberg; Peter J Felsburg; David J Rawlings; Hans-Peter Kiem
Journal:  Blood Adv       Date:  2018-05-08

Review 6.  Role of apoptosis in HIV disease pathogenesis.

Authors:  N Oyaizu; S Pahwa
Journal:  J Clin Immunol       Date:  1995-09       Impact factor: 8.317

7.  Molecular cloning and characterization of viruses isolated from chimpanzees with pathogenic human immunodeficiency virus type 1 infections.

Authors:  D M Mwaengo; F J Novembre
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Programmed death of T cells in human immunodeficiency virus infection. No correlation with progression to disease.

Authors:  L Meyaard; S A Otto; I P Keet; M T Roos; F Miedema
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.

Authors:  Julie M Decker; Kenneth P Zammit; Juliet L Easlick; Mario L Santiago; Denise Bonenberger; Beatrice H Hahn; Olaf Kutsch; Frederic Bibollet-Ruche
Journal:  Virology       Date:  2009-09-12       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.